Neeraj Bhala
Researcher Next ID · RN-023011
Researcher · Biochemistry, Genetics and Molecular Biology
Melbourne, United Kingdom
- Works count
- 232
- Citation count
- 136,722
- H-index
- 57
- i10-index
- 92
Research interests
Publications
Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
The Lancet. Gastroenterology & hepatology · 2022 · 10.1016/s2468-1253(22)00044-9
Global, regional, and national burden of colorectal cancer and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
Research Repository Portal (Ilam University of Medical Sciences) · 2022
Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
The Lancet · 2022 · https://doi.org/10.1016/s0140-6736(22)00847-9
British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults
Gut · 2021 · 10.1136/gutjnl-2021-325210
Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
Gastroenterology · 2020 · https://doi.org/10.1053/j.gastro.2020.01.043
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
The Lancet. Gastroenterology & hepatology · 2020 · https://doi.org/10.1016/s2468-1253(19)30349-8
Sharpening the global focus on ethnicity and race in the time of COVID-19
The Lancet · 2020 · 10.1016/s0140-6736(20)31102-8
The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
The Lancet. Gastroenterology & hepatology · 2019 · https://doi.org/10.1016/s2468-1253(19)30333-4
Review article: managing the adverse events caused by anti‐TNF therapy in inflammatory bowel disease
Alimentary Pharmacology & Therapeutics · 2019 · 10.1111/apt.15097
The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017
The Lancet. Gastroenterology & hepatology · 2019 · https://doi.org/10.1016/s2468-1253(19)30328-0
The use of faecal microbiota transplant as treatment for recurrent or refractoryClostridium difficileinfection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
Gut · 2018 · 10.1136/gutjnl-2018-316818
Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials
The Lancet. Gastroenterology & hepatology · 2018 · 10.1016/s2468-1253(18)30037-2
Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK
The Lancet · 2017 · 10.1016/s0140-6736(17)32866-0
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)32154-2
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015
The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)30819-x
Systematic review with meta‐analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection
Alimentary Pharmacology & Therapeutics · 2017 · 10.1111/apt.14201
Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016
The Lancet · 2017 · 10.1016/s0140-6736(17)32336-x
The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013
The Lancet · 2016 · 10.1016/s0140-6736(16)30579-7
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition
The Lancet · 2015 · https://doi.org/10.1016/s0140-6736(15)61340-x
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
The Lancet · 2014 · 10.1016/s0140-6736(14)60844-8
Epidemiology and Natural History of Patients with NAFLD
Current Pharmaceutical Design · 2013 · 10.2174/13816128113199990336
Measuring progress on NCDs: one goal and five targets
The Lancet · 2012 · 10.1016/s0140-6736(12)61692-4
Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys
The Lancet · 2012 · 10.1016/s0140-6736(12)61085-x
The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study
Hepatology · 2011 · 10.1002/hep.24491
Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis
Gut · 2005 · 10.1136/gut.2005.065862
Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort
Gut · 2005 · 10.1136/gut.2005.080317
Current projects
No projects listed.